Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.
Sponsored By: Representative Latta, Robert E. [R-OH-5]
Unknown
Summary
No summary available.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Latta, Robert E. [R-OH-5]
OH • R
Cosponsors
Rep. Dunn, Neal P. [R-FL-2]
FL • R
Sponsored 7/26/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov